Pulmonary Arterial Hypertension Treatment Market to Witness a Rise of US $6.5 Billion by 2028
Owing to non-responsive nature of several advance pharmacotherapies and high diagnosis and treatment costs, researchers and medical practitioners in the global pulmonary arterial hypertension treatment market are continually working on favorable and effective alternative treatment models and increase survival rate among the patients with pulmonary arterial hypertension.
View full press release